Medtech grants in Israel

Funds one large data platform that identifies shared biological markers for reward, motivation and impulsivity symptoms across Alzheimer's, depression, obesity and related disorders.

Funds training, twinning and digital-platform networks that raise ethics, regulatory and pharmacovigilance capacity across sub-Saharan African health authorities.

Closed

Co-funds Polish translational cancer-metabolism research done with an international team.

Funds beyond-proof-of-concept innovations that make infectious-disease prevention, treatment or diagnostics cheaper, more accessible or better suited to sub-Saharan Africa.

Closed

Pays biomedical New Approach Methodology developers a fixed EUR 300,000 lump-sum grant to validate animal-free testing methods and prepare them for regulatory use.

Closed

Funds research into how climate change drives non-communicable disease, mental health harm or infectious disease, so health systems can better anticipate and respond.

Funds one project mining research cohorts and biobanks to find causal links between infections and non-communicable diseases, aimed at new vaccines, diagnostics and early treatments.

Closed

Funds research into how environmental exposures interact with genetic and lifestyle factors to cause cancer in children, adolescents and young adults.

Open

Supports Israeli startups entering the United States market through free Detroit soft-landing services and local introductions.

Between cycles

Provides Michigan-based access and matchmaking to United States–Israel joint projects applying for BIRD conditional grants.

Between cycles

Connects Michigan and Israeli organizations through curated trade delegations and cross-border business matchmaking.

Between cycles

Funds Israeli pre-seed startups with early capital for first experiments and customer discovery.

Between cycles

Funds Israeli seed ventures with support for first commercial development and hiring.

Open

Supports Alzheimer’s and dementia drug development from preclinical readiness to early clinical testing across diverse modalities.

Open

Funds new biomarkers for Alzheimer's and related dementias through PET ligands, MRI, spinal fluid, and brain activity measures.

Open

Supports dementia prevention research through precision risk reduction, combination treatment testing, and effectiveness comparisons.

Offers $200,000 in prizes across five enterprise challenge streams for teams building quantum, AI and HPC solutions to real industrial problems.

Open

Awards $1 million to one winning mental-health research team, and $250,000 each to three runners-up, developing new interventions for anxiety, depression or psychosis, worldwide.

Open

Funds a consortium to build a new EIT Label-certified micro-credentials programme teaching entrepreneurship and innovation to healthcare students.

Funds small, high-risk exploratory research into reconstructive transplantation and vascularized composite allotransplantation for wounded Service Members and Veterans.

Open

Funds a £6.25 million challenge prize for innovations that improve snakebite outcomes worldwide.

Open

Supports global cancer teams through CRUK to validate novel therapeutic concepts toward patient solutions.

Open

Funds high-risk clinical trials of new ways to see inside the living human inner ear. A trial is compulsory, and NIH stays in the room.

Open

Funds building the imaging that can finally show hair cells and membranes inside a living human ear. A clinical trial is optional.